Is Abbott Laboratories Stock Halal?
Abbott Laboratories · ABT · NYSE
All 3 halal screening authorities with a published position rate Abbott Laboratories halal.
Abbott Laboratories (ABT) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 22.2% of market cap and cash plus interest-bearing securities 4.7% — both inside the 30% AAOIFI thresholds. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified.
Financial data as of 2026-03-31 · Screening basis: AAOIFI · Last reviewed 2026-06-15
HalalWallet is not a Shariah authority and does not issue religious rulings. We compile the most complete public record of what Shariah scholars, screening authorities, and mainstream standards say — reproduced from primary sources with dates and citations — and let you decide.
Do the halal screening authorities agree?
- HalalWallet (AAOIFI)· Halal
- Musaffa· Halal
- Zoya· Halal
All 3 halal screening authorities with a published position rate Abbott Laboratories halal.
Stances are normalized from each authority's own dated public position. Disagreement usually reflects a methodology or standard difference (ratio timing, market-cap vs total-assets denominator), not an error. For the fund screens (Wahed/HLAL, SP Funds/SPUS), only a confirmed holding that passed the fund's screen counts as a pass — a non-holding is left blank because absence can reflect index scope.
Is Abbott Laboratories Stock Halal?
All 3 halal screening authorities with a published position rate Abbott Laboratories halal. Abbott Laboratories (ABT) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 22.2% of market cap and cash plus interest-bearing securities 4.7% — both inside the 30% AAOIFI thresholds. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified.
- Interest-bearing debt / market cap: 22.2% (< 30%) — Pass
- Cash + interest-bearing securities / market cap: 4.7% (< 30%) — Pass
- Impermissible income / total revenue: 0.5% (< 5%) — Pass
- Financial ratios sourced from filings as of 2026-03-31.
How we read the evidence
HalalWallet's editorial synthesis of the screens, scholar positions, and sources documented on this page — not a religious ruling.
Abbott is a diversified healthcare company — medical devices (including its continuous glucose monitors), diagnostics, nutrition (Similac, Ensure), and branded generic pharmaceuticals. Crucially, none of those segments is conventional insurance, which is the activity that disqualifies a healthcare giant like UnitedHealth. Abbott's mix is permissible, and it passes the AAOIFI financial screens: interest-bearing debt around 22% of market cap, cash near 5%, and impermissible income about 0.5% of revenue.
Screeners including Zoya and Musaffa rate Abbott compliant. Its debt ratio is a touch higher than the cleanest names in the sector, so the usual discipline applies — re-check quarterly since the ratio moves with the share price — but there is no business-activity concern. Purify the small share of dividends attributable to incidental interest income.
Business Activity Screen
Abbott Laboratories is a diversified healthcare company spanning medical devices, diagnostics, established (branded generic) pharmaceuticals, and nutrition products. These are permissible healthcare activities and do not include conventional insurance.
Abbott passes the business-activity screen — its segments are medical devices, diagnostics, nutrition, and branded generic pharmaceuticals, none of which is conventional insurance or banking. Interest-bearing debt is about 22% of market cap, cash roughly 5%, and impermissible income about 0.5% of revenue — inside AAOIFI limits. Incidental interest income should be purified.
Financial Ratio Screen
| Screen | Value | AAOIFI limit | Result |
|---|---|---|---|
| Interest-bearing debt / market cap | 22.2% | < 30% | Pass |
| Cash + interest-bearing securities / market cap | 4.7% | < 30% | Pass |
| Impermissible income / total revenueInterest income $230.0M on $44.33B total revenue (Abbott Laboratories FY2025 (fiscal year ended 2025-12-31, Form 10-K)) = 0.5% — under AAOIFI's 5% limit. | 0.5% | < 5% | Pass |
Spot market cap at research date (consider trailing average for borderline names). Data as of 2026-03-31 · thresholds per AAOIFI Shariah standards.
This verdict uses the AAOIFI standard — the most widely used and, at a 30% debt limit, the most conservative mainstream Shariah standard. Interest-bearing debt and interest-bearing securities each stay under 30% of market cap, and impermissible income under 5% of revenue. Other standards (Dow Jones Islamic, S&P Shariah, MSCI Islamic, FTSE Yasaar) use ~33% limits or screen against total assets, so a borderline company can be rated differently by each. How we screen & why screeners disagree →
How Abbott Laboratories screens across Shariah standards
All three mainstream bases below reach the same conclusion for this company.
| Standard | Debt | Cash & interest securities | Limit / basis | Result |
|---|---|---|---|---|
| AAOIFI (our standard) | 22.2% | 4.7% | < 30% of market cap | Pass |
| Dow Jones Islamic / S&P Shariah thresholdDow Jones and S&P apply this limit against a trailing 24–36-month average market cap; shown here on the same point-in-time market cap for comparison. | 22.2% | 4.7% | < 33% of market cap | Pass |
| MSCI Islamic / FTSE Yasaar basisTotal-assets denominator. MSCI/FTSE also apply entry/exit buffers and a receivables screen we do not reproduce. | 30.8% | 6.6% | < 33.33% of total assets | Pass |
HalalWallet computation reproducing each standard's threshold and denominator from public filings (balance sheet as of 2026-03-31) — not the providers' licensed index determinations, which can differ. Debt is interest-bearing borrowings (operating leases excluded). The impermissible-income screen (< 5% of revenue) is common to all of these standards and is shown in the ratio table above. Dow Jones and S&P apply their limit against a trailing 24–36-month average market cap; MSCI and FTSE add entry/exit buffers and a receivables screen. Full methodology →
Scholars' & Screeners' Positions
Published positions, cited as stated. Screeners can reach different conclusions on the same company because of ratio timing and methodology differences — we report the disagreement rather than flatten it.
Purification
Even Shariah-compliant companies typically earn a small amount of incidental interest on corporate cash. The standard practice is to purify: donate the proportion of your dividends (and, per some scholars, capital gains) attributable to impermissible income. Our purification calculator automates the math from your holding and the company's disclosed figures.
Purification calculatorKeep your portfolio halal
A pass today isn't a pass forever — ratios drift across thresholds between filings. A halal screener monitors holdings continuously.
Related guides
Stay Updated
Get alerted when screening statuses change — new financials, new authority positions, new verdicts
No spam ever. Unsubscribe in one click.
The Final Step: Your Scholar Conversation
Major whether Abbott Laboratories is halal decisions involve nuances that vary by scholarly opinion and personal circumstance — which is why HalalWallet is built as the research step, not the ruling. We do the homework on comparisons, structures, and oversight; a qualified Islamic scholar, your local imam, or a Shariah-certified financial advisor covers what no comparison site can — guidance specific to your situation. Bring your shortlist to that conversation so it starts at the decision, not the basics.
How to use this comparison: HalalWallet is an independent educational comparison platform — by design, we do not provide financial, legal, or religious advice. We do the research homework so your final checks are quick and personal.
Product structures and Shariah oversight vary by provider, so finish with three built-in steps:
- Confirm current terms and halal compliance directly with the provider — their quote is final.
- Review the contract structure (Murabaha, Ijara, Musharakah, etc.) and any disclosed Shariah board opinions.
- Bring your shortlist to a qualified Islamic finance advisor or scholar, so the conversation is about your situation, not the basics.
Frequently Asked Questions
Sources and review process
This page is reviewed against HalalWallet editorial standards and source documentation.
Reviewed by: HalalWallet Editorial Team
Last reviewed: 2026-07-01
How to cite this page
Preferred format (HTML):
AI / agent mirror (Markdown, CC BY 4.0):
Bulk feed record: verdict.abbott-laboratories-stock in /api/llm-feed.json
For time-sensitive claims (rates, fees, state availability), please verify directly with the provider's official documentation and note the retrieval date.
Editorial Team, HalalWallet
Independent halal finance research
Reviewed quarterly and updated for major content changes.